A new bacterial threat, the carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP), is rapidly spreading in clinical environments in China, posing a significant public health challenge. This pathogen is simultaneously multidrug-resistant, highly virulent, and highly transmissible, making it a devastating threat.
